Surgery Partners, Inc. (SGRY) Misses Q3 EPS by 15c, Revenue Beats

Surgery Partners, Inc. (NASDAQ: SGRY) reported Q3 EPS of ($0.19), $0.15 worse than the analyst estimate of ($0.04). Revenue for the quarter came in at $443.9 million versus the consensus estimate of $432.71 million.

GUIDANCE:

Surgery Partners, Inc. sees FY2018 revenue of $1.75-1.8 billion, versus the consensus of $1.79 billion.

• Adjusted EBITDA in the range of $230 million to $235 million. The Company now expects to deploy at least $100 million in capital for acquisitions in FY’18.

For earnings history and earnings-related data on Surgery Partners, Inc. (SGRY) click here.

You May Also Be Interested In

• Greenbrier Cos. (GBX) Reports In-Line Q3 EPS
• Biogen expects $164M R&D charge to hit Q2 2026 earnings
• Yara to buy Gulf Coast Ammonia plant in Texas for $1.3B